Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 315

1.

Recovery of viable CD34+ cells from cryopreserved hemopoietic progenitor cell products.

Sartor M, Antonenas V, Garvin F, Webb M, Bradstock KF.

Bone Marrow Transplant. 2005 Aug;36(3):199-204.

PMID:
15937512
2.

CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.

Kasow KA, Sims-Poston L, Eldridge P, Hale GA.

Biol Blood Marrow Transplant. 2007 May;13(5):608-14. Epub 2007 Mar 23.

3.

Fresh PBSC harvests, but not BM, show temperature-related loss of CD34 viability during storage and transport.

Antonenas V, Garvin F, Webb M, Sartor M, Bradstock KF, Gottlieb D.

Cytotherapy. 2006;8(2):158-65.

PMID:
16698689
5.

Post-thaw viable CD34(+) cell count is a valuable predictor of haematopoietic stem cell engraftment in autologous peripheral blood stem cell transplantation.

Lee S, Kim S, Kim H, Baek EJ, Jin H, Kim J, Kim HO.

Vox Sang. 2008 Feb;94(2):146-52. Epub 2007 Nov 19.

PMID:
18028260
6.

Number of viable CD34(+) cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation.

Allan DS, Keeney M, Howson-Jan K, Popma J, Weir K, Bhatia M, Sutherland DR, Chin-Yee IH.

Bone Marrow Transplant. 2002 Jun;29(12):967-72.

7.

Effect of cell concentration on bone marrow and peripheral blood stem cell cryopreservation.

Rowley SD, Bensinger WI, Gooley TA, Buckner CD.

Blood. 1994 May 1;83(9):2731-6.

8.

Positive selection of CD34+ cells from cryopreserved peripheral blood stem cells after thawing: technical aspects and clinical use.

Bohbot A, Lioure B, Faradji A, Schmitt M, Cuillerot JM, Laplace A, Oberling F.

Bone Marrow Transplant. 1996 Feb;17(2):259-64.

PMID:
8640176
9.

Determining post-thaw CD34+ cell dose of cryopreserved haematopoietic progenitor cells demonstrates high recovery and confirms their integrity.

Reich-Slotky R, Colovai AI, Semidei-Pomales M, Patel N, Cairo M, Jhang J, Schwartz J.

Vox Sang. 2008 May;94(4):351-7. doi: 10.1111/j.1423-0410.2007.001028.x. Epub 2008 Jan 2.

PMID:
18179677
10.

CXCR4 expression on transplanted peripheral blood CD34+ cells: relationship to engraftment after autologous transplantation in a cohort of multiple myeloma patients.

Hicks C, Isaacs A, Wong R, Chong BH.

Ann Hematol. 2011 May;90(5):547-55. doi: 10.1007/s00277-010-1097-8. Epub 2010 Oct 19.

PMID:
20957366
11.

Extensive early apoptosis in frozen-thawed CD34-positive stem cells decreases threshold doses for haematological recovery after autologous peripheral blood progenitor cell transplantation.

de Boer F, Dräger AM, Pinedo HM, Kessler FL, van der Wall E, Jonkhoff AR, van der Lelie J, Huijgens PC, Ossenkoppele GJ, Schuurhuis GJ.

Bone Marrow Transplant. 2002 Feb;29(3):249-55.

12.

Isolation of purified autologous peripheral blood CD34+ cells with low T cell content using CliniMACS device--a local experience.

Leong CF, Habsah A, Teh HS, Goh KY, Fadilah SA, Cheong SK.

Malays J Pathol. 2008 Jun;30(1):31-6.

13.

Peripheral blood and BM CD34+ CD38- cells show better resistance to cryopreservation than CD34+ CD38+ cells in autologous stem cell transplantation.

Ojeda-Uribe M, Sovalat H, Bourderont D, Brunot A, Marr A, Lewandowski H, Chabouté V, Peter P, Henon P.

Cytotherapy. 2004;6(6):571-83.

PMID:
15764022
14.

Bone marrow CD34+ cell count is predictive for adequate peripheral progenitor cell collection.

Corso A, Varettoni M, Mangiacavalli S, Zappasodi P, Klersy C, Rusconi C, Colucci E, Lorenzi A, Troletti D, Consensi E, Lazzarino M.

Leuk Res. 2005 Feb;29(2):159-63.

PMID:
15607364
15.

Kinetics of hemopoietic recovery after peripheral blood stem cell transplantation: impact of stem cell purification and G-CSF.

Piccirillo N, Sorà F, Laurenti L, Chiusolo P, Serafini R, Cicconi S, Leone G, Sica S.

Am J Hematol. 2002 Jan;69(1):7-14.

PMID:
11835324
16.

Long-term follow-up of patients with non-Hodgkin lymphoma following myeloablative therapy and autologous transplantation of CD34+-selected peripheral blood progenitor cells.

Witzens-Harig M, Heilmann C, Hensel M, Kornacker M, Benner A, Haas R, Fruehauf S, Ho AD.

Stem Cells. 2007 Jan;25(1):228-35.

17.

Higher infused CD34+ hematopoietic stem cell dose correlates with earlier lymphocyte recovery and better clinical outcome after autologous stem cell transplantation in non-Hodgkin's lymphoma.

Yoon DH, Sohn BS, Jang G, Kim EK, Kang BW, Kim C, Kim JE, Kim S, Lee DH, Lee JS, Park SJ, Park CJ, Huh J, Suh C.

Transfusion. 2009 Sep;49(9):1890-900. doi: 10.1111/j.1537-2995.2009.02202.x. Epub 2009 May 11.

PMID:
19453991
18.

Comparison of two different methods for CD34+ selection and T cell depletion in peripheral blood stem cell grafts--our experiences with CellPro, E rosetting and CliniMACS technique.

Poloucková A, Vodvárková A, Kobylka P, Hrubá A, Gasová Z, Marinov I, Fales I, Sedlácek P, Kozák T, Starý J.

Neoplasma. 2001;48(5):374-81.

PMID:
11845982
19.

Debulking blood stem cell collections by density gradient centrifugation in a closed-vessel system.

Przepiorka D, Lu JG, Anderlini P, Körbling M, Donato M, Champlin R, Gee AP, van Vlasselaer P.

Cytotherapy. 1999;1(2):111-7.

PMID:
19746587
20.

Effect of CD34 cell dose on hematopoietic reconstitution and outcome in 508 patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation.

Klaus J, Herrmann D, Breitkreutz I, Hegenbart U, Mazitschek U, Egerer G, Cremer FW, Lowenthal RM, Huesing J, Fruehauf S, Moehler T, Ho AD, Goldschmidt H.

Eur J Haematol. 2007 Jan;78(1):21-8. Epub 2006 Sep 28.

PMID:
17042762

Supplemental Content

Support Center